These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2392594)

  • 1. [Determination of antibodies against Borrelia burgdorferi in patients with morphea, lichen sclerosus et atrophicus and erythema chronicum migrans].
    Pinazo Canales I; Betlloch Mas I; Mestre Bauza F; Salva Armengod F; Parras Vázquez F; Alomar Cardell J
    Rev Clin Esp; 1990 Apr; 186(7):320-3. PubMed ID: 2392594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
    Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
    Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-Borrelia burgdorferi antibodies in chronic erythema migrans, benign lymphadenosis cutis, scleroderma and scleroatrophic lichen].
    Afa G; Caprilli F; Crescimbeni E; Morrone A; Prignano G; Fazio M
    G Ital Dermatol Venereol; 1990 Sep; 125(9):369-73. PubMed ID: 2079346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species.
    Stanek G; Breier F; Menzinger G; Schaar B; Hafner M; Partsch H
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):951-6. PubMed ID: 10666807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients.
    Glatz M; Golestani M; Kerl H; Müllegger RR
    Arch Dermatol; 2006 Jul; 142(7):862-8. PubMed ID: 16847202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful amplification of DNA specific for Finnish Borrelia burgdorferi isolates in erythema chronicum migrans but not in circumscribed scleroderma lesions.
    Ranki A; Aavik E; Peterson P; Schauman K; Nurmilaakso P
    J Invest Dermatol; 1994 Mar; 102(3):339-45. PubMed ID: 8120417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of different Borrelia burgdorferi sensu lato strains for detection of immune response in patients with erythema migrans.
    Merljak Skocir L; Ruzić-Sabljić E; Maraspin-Carman V; Lotric-Furlan S; Logar M; Strle F
    Int J Med Microbiol; 2008 Jul; 298(5-6):493-504. PubMed ID: 17892971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody responses to borrelia IR(6) peptide variants and the C6 peptide in Swedish patients with erythema migrans.
    Tjernberg I; Sillanpää H; Seppälä I; Eliasson I; Forsberg P; Lahdenne P
    Int J Med Microbiol; 2009 Aug; 299(6):439-46. PubMed ID: 19138558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Borrelia burgdorferi DNA (B garinii or B afzelii) in morphea and lichen sclerosus et atrophicus tissues of German and Japanese but not of US patients.
    Fujiwara H; Fujiwara K; Hashimoto K; Mehregan AH; Schaumburg-Lever G; Lange R; Schempp C; Gollnick H
    Arch Dermatol; 1997 Jan; 133(1):41-4. PubMed ID: 9006371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of immunofluorescence test (IFT) and immuno (western) blot (WB) test in patients with erythema migrans.
    Ruzić-Sabljić E; Maraspin V; Cimperman J; Lotric-Furlan S; Strle F
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):586-90. PubMed ID: 12422606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for spirochetal origin of circumscribed scleroderma (morphea).
    Aberer E; Stanek G; Ertl M; Neumann R
    Acta Derm Venereol; 1987; 67(3):225-31. PubMed ID: 2442935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Borrelia burgdorferi antibodies in scleroderma circumscripta, lichen sclerosus et atrophicus, erythema nodosum, granuloma annulare, erythema annulare and chronic urticaria].
    Svecova D; Buchvald J
    Bratisl Lek Listy; 2000; 101(4):194-9. PubMed ID: 10914463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No evidence for Borrelia burgdorferi infection in lesions of morphea and lichen sclerosus et atrophicus in Spain. A prospective study and literature review.
    Alonso-Llamazares J; Persing DH; Anda P; Gibson LE; Rutledge BJ; Iglesias L
    Acta Derm Venereol; 1997 Jul; 77(4):299-304. PubMed ID: 9228224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North America.
    Dillon WI; Saed GM; Fivenson DP
    J Am Acad Dermatol; 1995 Oct; 33(4):617-20. PubMed ID: 7673495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification.
    Schempp C; Bocklage H; Lange R; Kölmel HW; Orfanos CE; Gollnick H
    J Invest Dermatol; 1993 May; 100(5):717-20. PubMed ID: 8491994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serodiagnosis in dermatological diseases in Borrelia burgdorferi infections].
    Hofmann H; Meyer-König U
    Hautarzt; 1990 Aug; 41(8):424-31. PubMed ID: 2272826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and serological diagnosis of Borrelia burgdorferi infection among patients with diagnosed Erythema migrans.
    Kondrusik M; Grygorczuk S; Skotarczak B; Wodecka B; Rymaszewska A; Pancewicz S; Zajkowska J; Swierzbińska R; Hermanowska-Szpakowicz T
    Ann Agric Environ Med; 2007; 14(2):209-13. PubMed ID: 18247452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Borrelia burgdorferi, clinical aspects, cultivation and identification of the pathogen in erythema migrans in Berlin].
    Ott A; Schönberg A
    Z Hautkr; 1989 Aug; 64(8):644-8. PubMed ID: 2678789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spirochetal forms in the dermal lesions of morphea and lichen sclerosus et atrophicus.
    Ross SA; Sánchez JL; Taboas JO
    Am J Dermatopathol; 1990 Aug; 12(4):357-62. PubMed ID: 2393064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinical and serological manifestations of Lyme disease in Russia].
    Anan'eva LP; Skripnikova IA; Barskova VG; Steere AC
    Ter Arkh; 1995; 67(11):38-42. PubMed ID: 8571249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.